The global brachytherapy market was valued at $0.83 billion in 2022, and is projected to reach $1.6 billion by 2032, growing at a CAGR of 7.1% from 2023 to 2032.
The Brachytherapy Market Size was analyzed qualitatively and quantitatively from 2022 to 2032. The brachytherapy market experienced an increase at a CAGR of around 7.1% from 2023 to 2032. Most of the growth during this period was derived from the North America owing to the rise in the number of key players, rising disposable incomes, as well as well-established presence of domestic companies in the region.
Request a Sample@ https://www.qyresearchmedical.com/sample/119559
Growth of the global brachytherapy Brachytherapy Market Size is majorly driven by rise in the prevalence of cancer, increase in the number of geriatric populations, and rise in the prevalence of cancer. Brachytherapy is mainly used for the treatment of the cancer. For instance, according to the data published by World Cancer Research Fund International in 2022,There were an estimated 18.1 million cancer cases around the world.
Furthermore, geriatric population is majorly susceptible to suffer from various cancers diseases such as prostate cancer, breast cancer and lung cancer. For instance, according to the U.S. Census Bureau data published in December 2022, more than 56 million adults ages 65 years of the nation’s population. As per the same source, it is estimated to reach up to 85.7 million by 2050. Moreover, increase in adoption of radiation therapy for the treatment of cancer contributes to the growth of the market.
The brachytherapy market is segmented on the basis of product type, techniques, application, end user, and region. Depending on the product type, the market is classified into seeds, applicators & afterloaders, and electronic brachytherapy. Based on technique, the market is classified into high dose rate (HDR), and low dose rate (LDR). On the basis of application, the market is classified into gynecological cancer, prostate cancer, breast cancer, and others. On the basis of end user, it is fragmented into hospitals, specialty clinics, and others. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
By Product Type
The market is classified into seeds, applicators & afterloaders, and electronic brachytherapy. The seeds segment dominated the market in 2022 and is expected to continue this trend during the forecast period, owing to rise in prevalence of cancer and increase in the number of product launch for seeds implants.
The market is classified into high dose rate (HDR), and low dose rate (LDR). The low dose rate (LDR) segment generated maximum revenue in 2022 and is expected to witness highest CAGR during the forecast period, owing to high adoption of low dose rate techniques for the treatment of cancer, increase in prevalence of prostate cancer, breast cancer and gynecological cancer.
The market is fragmented into gynecological cancer, prostate cancer, breast cancer, and others. The prostate cancer segment dominated the Brachytherapy Market Share in 2022 and is expected to continue this trend during the Brachytherapy Market Forecast period, owing to rise in prevalence of prostate cancer increase in the number of geriatric populations.
The brachytherapy market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America brachytherapy market is expected to grow during the forecast period owing to an increase in the prevalence of prostate cancer cancer, breast cancer and gynecological cancer is anticipated to fuel the demand for brachytherapy which drives the growth of market in North America.
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the brachytherapy market analysis from 2022 to 2032 to identify the prevailing Brachytherapy Market Opportunity.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter’s five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the brachytherapy market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global brachytherapy market trends, key players, market segments, application areas, and market growth strategies.
Segments Covered in the Report:
|Product Type||End User||Application|
Applicators and Afterloaders
| Gynecological Cancer
Brachytherapy Market Key Players And Regions
|By Region||Key Market Players|
| North America
| Argon Medical Devices, Inc.
Eckert & Ziegler BEBIG
Merit Medical Systems, Inc.
IsoAid, Carl Zeiss AG
Buy quantitative research Report at discounted price – USD 1599 https://www.qyresearchmedical.com/report/checkout/119559/
You can place an order or ask any questions, please feel free to contact [email protected] | +1 9197 992 333
QYResearch Medical has more than 4000 global well-known customers, covering more than 30 industries including pharmaceuticals, medical technology & devices, healthcare services etc. Company services cover one-stop solution as Data-Analysis-Suggestion-Consulting Implementation. Research regions cover North America, Europe, Latin America, Middle East and Africa, Asia- Pacific.
For Latest Update Follow Us:
URL – http://www.qyresearchmedical.com/